Bio-Rad Labs (BIO) Q4 Revs Beat Views
Tweet
Share
E-mail
Get Alerts BIO Hot Sheet
Price: $283.67 +4.94%
Revenue Growth %: -4.3%
Financial Fact:
Cost of goods sold: 236.55M
Today's EPS Names:
DTGI, CRMT, MAYS, More
Revenue Growth %: -4.3%
Financial Fact:
Cost of goods sold: 236.55M
Today's EPS Names:
DTGI, CRMT, MAYS, More
Join SI Premium – FREE
Bio-Rad Labs (NYSE: BIO) reported Q4 EPS of $2.32, which includes tax gains and does not compare to the analyst estimate of $1.26. Revenue for the quarter came in at $620.4 million versus the consensus estimate of $619.15 million.
For earnings history and earnings-related data on Bio-Rad Labs (BIO) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- JPMorgan raises S&P 500 target to 7,800, says earnings revision ’unprecedented’
- GTA VI to catalyze a multi-year improvement in earnings power for TTWO, BTIG says
- Benchmark Reiterates Buy Rating on Cineverse (CNVS) Ahead of Q4 Results
Create E-mail Alert Related Categories
Earnings, GuidanceRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
